GHRL and dyspepsia: The review shows evidences that ghrelin and its (receptor)agonists possess a strong prokinetic potential to serve in the treatment of diabetic, neurogenic or idiopathic gastroparesis andpossibly, chemotherapy-associated dyspepsia, postoperative, septic or post-burn ileus, opiate-induced bowel dysfunction and chronicidiopathic constipation.